…did not report any overall benefits in the trial’s many subjective measures of well-being. And to mention one other odd point…According to a 2019 study cited by the authors, the…
…a challenging condition yields null results. That’s what happened in 2019 with a trial of rituximab for ME/CFS, published in Annals of Internal Medicine. Findings from earlier research had suggested…
…Sciences in 2018, the National Academy of Medicine in 2019, to and the American Academy of Arts and Sciences in 2021. She was one of the four scientific organizers of…
The TWiVerers continue their coverage of the new coronavirus outbreak in China, as the number of cases increase dramatically and the virus begins person-to-person transmission in other countries. Click arrow…
In this week’s coverage of the coronavirus epidemic, the TWiV team discusses the fatality rate, China’s initial reaction to the outbreak, conspiracy theories, how long the virus remains infectious on…
The spike glycoprotein of the newly emerged SARS-CoV-2 contains a potential cleavage site for furin proteases. This observation has implications for the zoonotic origin of the virus and its epidemic…
